Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
24. May 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 8923
Articles 1 - 20 / 178451
Transcriptomic insights into epigenetic and immunomodulatory roles of nuclear histone genes in bladder cancer: A bioinformatics approach.
Adv Protein Chem Struct Biol
Elavarasu SM, Asheem I, M N, S UK, Magesh R, K S, C GPD.
PMID: 42177073 [PubMed - indexed for MEDLINE]
Elective Nodal Radiotherapy in Localized Prostate Cancer: A Meta-Analysis.
Int J Radiat Oncol Biol Phys
Roy S, Jia AY, Zaorsky NG, Spratt DE.
PMID: 42176865 [PubMed - as supplied by publisher]
Improving physical activity in men with prostate cancer through wearable devices and online education: Randomized controlled trial.
Int J Med Inform
O'Neill M, Sabiston CM, Tomlinson G, Santa Mina D, Sibley D, Alibhai SMH.
PMID: 42176601 [PubMed - as supplied by publisher]
Thromboembolic Events after Surgery for Localized Prostate Cancer: Incidence, Risk Factors, and Survival Outcomes.
Clin Appl Thromb Hemost
Noh Y, Park H, Shin DY, Hong J, Cho H, Byun JM, Koh Y, Jeong SH, Yuk H, Cho SY, Jeong CW, Ku JH, Kwak C, Kim I.
PMID: 42175944 [PubMed - indexed for MEDLINE]
Testosterone and docetaxel treatment effect on mortality risk in nonmetastatic high-risk prostate cancer: A predictive biomarker analysis.
Cancer
Zeng J, Chen MH, Wu J, Xie W, Ravi P, Nguyen P, Sandler H, D'Amico AV.
PMID: 42175549 [PubMed - indexed for MEDLINE]
The impact of the COVID-19 pandemic in 2020 on the diagnosis, treatment, and cancer-specific survival of major urological cancers: An observational study.
Medicine (Baltimore)
Wang M, Jia K, Wang Y, Yuan D, Huang L, Li K, Zhong X.
PMID: 42175471 [PubMed - indexed for MEDLINE]
How Good Are Patient-Facing LLMs at Survivorship Questions? A Comparative User Evaluation Across Four Chatbots.
Stud Health Technol Inform
Khairat S, Masoumi S, Mehraby H, Geracitano J.
PMID: 42175007 [PubMed - indexed for MEDLINE]
Representation of Ordinal Features: Supervised Embeddings in the Survival Prediction of Prostate Cancer Patients.
Stud Health Technol Inform
Schwarz L.
PMID: 42174784 [PubMed - indexed for MEDLINE]
Pomegranate in Cancer Therapy: A Review of Anticancer Potential, Mechanisms and Clinical Challenges in Breast, Colon and Prostate Cancers.
Phytother Res
Kitic D, Miladinovic B, Randjelovic M, Szopa A, Seidel V, Sharifi-Rad J, Setzer WN, Calina D.
PMID: 42174764 [PubMed - as supplied by publisher]
IL20RB as a potential biomarker for prognosis in clear cell renal cell carcinoma.
BMC Cancer
Yuehua L, Dong X, Guiqiang L, Feiqiang R, Bin X, Wei T, Jie W, Yu G.
PMID: 42174479 [PubMed - as supplied by publisher]
Integrating lifestyle and clinical data in prostate cancer: expert assessment of a questionnaire.
World J Urol
Leitão C, Monteiro L, Fardilha M, Roque F, Herdeiro MT.
PMID: 42174308 [PubMed - indexed for MEDLINE]
Global research trends and thematic evolution in robot-assisted radical nephrectomy: a bibliometric and visualisation study.
J Robot Surg
Qiu Z, Duan C, Chen K, Yin C.
PMID: 42174280 [PubMed - indexed for MEDLINE]
Omission of indwelling urinary catheter after robotic partial nephrectomy in female patients: a single-surgeon experience.
J Robot Surg
Choi JW, Saxena S, Rajendran P, Kourouma A, Billah MS, Ahmed M.
PMID: 42174186 [PubMed - indexed for MEDLINE]
Early-access Use of Radioligand Therapy in Prostate Cancer.
Eur Urol Focus
François C, Bailly C.
PMID: 42173792 [PubMed - as supplied by publisher]
Comment on "Association of cardiovascular-kidney-metabolic syndrome with cardiovascular, cancer, and all-cause mortality among US adults: A prospective study".
J Formos Med Assoc
Shubham, Mathur A.
PMID: 42173781 [PubMed - as supplied by publisher]
Epigenetic signatures and risk determinants in bladder cancer: Implications for diagnostic and therapeutic interventions.
Urol Oncol
Pradhan B, Mishra P, Dash P, Niharika, Baral T, Mishra J, Chakraborty S, Nandi P, Patra SK.
PMID: 42173769 [PubMed - as supplied by publisher]
Racial and ethnic differences in prostate cancer screening outcomes in the United States: A secondary analysis of the prostate, lung, colorectal, and ovarian cancer trial.
Prev Med
Joung HH, Martin DN, Jones RA.
PMID: 42173201 [PubMed - as supplied by publisher]
Prostate imaging after focal ablation scoring after irreversible electroporation treatment in localized prostate cancer: Diagnostic accuracy and inter-reader agreement.
Eur J Radiol
Altan SA, Sakar R, Onay A, Kizil PG, Mercan ED, Gunhan O, Adsan O.
PMID: 42172740 [PubMed - as supplied by publisher]
Environmental Nonessential Element Exposure and Urologic Cancer: A Systematic Review and Meta-Analysis.
JAMA Netw Open
Deng Z, Li J, Ji R, Delgado JR, Yim SHL, Kachuri L, Cardenas A, Graff RE, Leppert JT, Dennis LK, Chung BI, Langston ME.
PMID: 42172026 [PubMed - indexed for MEDLINE]
TFPI2 expression predicts resistance to immunotherapy plus tyrosine kinase inhibitor and informs first-line therapy selection in metastatic renal cell carcinoma.
Cell Oncol (Dordr)
Wang J, Du L, Wang Y, Wang H, Zhu Y, Xu X.
PMID: 42171882 [PubMed - as supplied by publisher]
Articles 1 - 20 / 178451
Page 1 of 8923
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy